Document Detail


Hypotensive mechanism of acetyl glyceryl ether phosphorylcholine (AGEPC) in dogs. Effects on hemodynamics and humoral factors.
MedLine Citation:
PMID:  3862138     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
One-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphorylcholine (AGEPC) was intravenously administered to anesthetized dogs to study the effects on hemodynamics and several endocrine factors. The effect of AGEPC on local blood flow was also studied by direct intra-arterial injection. Following intravenous injection, blood pressure and cardiac output decreased significantly (p less than 0.001). Changes in total peripheral resistance (TPR) and heart rate were biphasic. TPR increased significantly (p less than 0.01) after an initial slight reduction. Heart rate decreased significantly (p less than 0.01) with only a transient slight elevation. Femoral blood flow was increased (p less than 0.001) by intraarterial injection and decreased (p less than 0.05) by intravenous administration. Plasma norepinephrine (p less than 0.001), epinephrine (p less than 0.01), thromboxane B2 (p less than 0.001), 6-0-PGF1 alpha (p less than 0.01), aldosterone (p less than 0.001) and cortisol (p less than 0.001) were elevated, but plasma renin activity did not change. These results suggest that the hypotensive mechanism of AGEPC is due to both cardiosuppression and vasodilation. AGEPC increased plasma catecholamines, thromboxane A2, PGI2, aldosterone and cortisol which, in turn, may modify hemodynamics.
Authors:
A Otsuka; F Masugi; T Ogihara; S Saeki; M Nagano; Y Koyama; Y Tabuchi; Y Kumahara
Related Documents :
15018248 - Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrog...
234268 - Results of adrenal surgery in patients with hypertension, aldosterone excess, and low p...
17215648 - Resistant hypertension: prevalence and evolving concepts.
3346058 - Total plasma dopamine/norepinephrine ratio in catecholamine-secreting tumors. its relat...
17753258 - Pressure dependence of superconductivity in single-phase k3c60.
16957428 - Blood pressure components in clinical hypertension.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Prostaglandins, leukotrienes, and medicine     Volume:  19     ISSN:  0262-1746     ISO Abbreviation:  Prostaglandins Leukot Med     Publication Date:  1985 Jul 
Date Detail:
Created Date:  1985-10-23     Completed Date:  1985-10-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8206868     Medline TA:  Prostaglandins Leukot Med     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  25-35     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldosterone / blood
Animals
Antihypertensive Agents*
Blood Cells / drug effects
Blood Pressure / drug effects
Cardiac Output / drug effects
Catecholamines / blood
Dogs
Fatty Acids, Unsaturated / blood
Hemodynamics / drug effects*
Hormones / blood*
Hydrocortisone / blood
Platelet Activating Factor / physiology*
Regional Blood Flow / drug effects
Vasodilation / drug effects
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Catecholamines; 0/Fatty Acids, Unsaturated; 0/Hormones; 0/Platelet Activating Factor; 50-23-7/Hydrocortisone; 52-39-1/Aldosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The efflux from and the metabolism of 3H-norepinephrine in sow Graafian follicles. Variable involvem...
Next Document:  Platelet thromboxane production in liver cirrhosis.